Font: Financial Modeling Prep • May 19, 2026
Euronext is a leading European stock exchange group. It operates regulated markets in several European countries, providing essential services like stock listings, trading, and market data. The company recently released its latest quarterly earnings report, a key event for investors tracking its financial performance and market position.
Ahead of the May 19, 2026, release, financial analysts set an earnings per share estimate of $2.27 for Euronext. They also expected revenue to be around $590.84 million. The company's actual reported underlying revenue and income for the first quarter was €528.50 million.
As highlighted by Reuters, Euronext's results beat market expectations. The company reports its eighth straight quarter of double-digit growth, with revenue and income up 15.3%. This increase comes from robust trading volumes, record performance in non-volume related business, and its recent strategic acquisition of the Athens Stock Exchange.
Looking at its investment valuation metrics, Euronext has a trailing Price-to-Earnings (P/E) ratio of 27.37. This means investors are paying $27.37 for every dollar of the company's past earnings. Its Price-to-Sales (P/S) ratio is 8.27, showing the price paid for each dollar of sales.
The company's financial health remains robust. It has a key financial metric, the Debt-to-Equity ratio, of 0.76, indicating it has less debt than shareholder equity. A strong current ratio of 5.00, a key liquidity indicator, also shows Euronext has five times the assets needed to cover its short-term financial obligations.
|
TZA§>
Direxion Daily Small Cap Bear 3X ETF
|
$4.83
-7.29%
|
|
SLXN§>
Silexion Therapeutics Ltd.
|
$0.53
96.95%
|
|
HAO§>
Haoxi Health Technology Limited
|
$0.01
0.71%
|
|
SOXS§>
Direxion Daily Semiconductor Bear 3X ETF
|
$8.54
-14.00%
|
|
MEHA§>
Functional Brands, Inc. Common Stock
|
$0.09
21.95%
|
|
JUNS§>
Jupiter Neurosciences, Inc.
|
$0.21
-35.94%
|
|
PHGE§>
BiomX Inc.
|
$0.60
59.60%
|
|
WOK§>
WORK Medical Technology Group Ltd.
|
$0.19
-19.57%
|
|
HCWB§>
HCW Biologics Inc.
|
$2.43
129.25%
|
|
GDC§>
GD Culture Group Limited
|
$0.12
-17.44%
|